{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T12:01:09Z","timestamp":1774353669468,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26293032"],"award-info":[{"award-number":["26293032"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.xphs.2017.04.032","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T04:46:42Z","timestamp":1493182002000},"page":"2576-2582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Involvement of Proton-Coupled Organic Cation Antiporter in Varenicline Transport at Blood-Brain Barrier of Rats and in Human Brain Capillary Endothelial Cells"],"prefix":"10.1016","volume":"106","author":[{"given":"Toshiki","family":"Kurosawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Okura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumasa","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kusuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiharu","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2017.04.032_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1358\/dot.2007.43.2.1069956","article-title":"Varenicline: new treatment with efficacy in smoking cessation","volume":"43","author":"Reus","year":"2007","journal-title":"Drug Today"},{"key":"10.1016\/j.xphs.2017.04.032_bib2","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1476-5381.2010.00682.x","article-title":"Pre-clinical properties of the \u03b14\u03b22 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence","volume":"160","author":"Rollema","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.xphs.2017.04.032_bib3","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1021\/jm050069n","article-title":"Varenicline: an \u03b14\u03b22 nicotinic acetylcholine receptor partial agonist for smoking cessation","volume":"48","author":"Coe","year":"2005","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.xphs.2017.04.032_bib4","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2165\/11537850-000000000-00000","article-title":"A\u00a0review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessation","volume":"49","author":"Faessel","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.xphs.2017.04.032_bib5","series-title":"Drug Delivery to the Brain: Physiological Concepts, Methodologies and Approaches","first-page":"23","article-title":"Chapter 2: Recent progress in blood-brain barrier and blood-CSF barrier transport research","author":"Tachikawa","year":"2014"},{"key":"10.1016\/j.xphs.2017.04.032_bib6","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/j.1476-5381.2011.01724.x","article-title":"OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies","volume":"165","author":"Roth","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.xphs.2017.04.032_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.xphs.2017.04.032_bib8","doi-asserted-by":"crossref","first-page":"11419","DOI":"10.1158\/0008-5472.CAN-05-1271","article-title":"ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier","volume":"65","author":"Bronger","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.xphs.2017.04.032_bib9","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1021\/mp200129p","article-title":"Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels","volume":"8","author":"Shawahna","year":"2011","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2017.04.032_bib10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/2045-8118-10-8","article-title":"Functional expression of a proton-coupled organic cation (H+\/OC) antiporter in human brain capillary endothelial cell line hCMEC\/D3, a human blood\u2013brain barrier model","volume":"10","author":"Shimomura","year":"2013","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.xphs.2017.04.032_bib11","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1124\/dmd.108.022087","article-title":"Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone","volume":"36","author":"Okura","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.xphs.2017.04.032_bib12","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1248\/bpb.17.676","article-title":"Transport mechanism of an H1-antagonist at the blood-brain barrier: transport mechanism of mepyramine using the carotid injection technique","volume":"17","author":"Yamazaki","year":"1994","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.xphs.2017.04.032_bib13","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1002\/jps.22567","article-title":"Diphenhydramine active uptake at the blood\u2013brain barrier and its interaction with oxycodone in\u00a0vitro and in\u00a0vivo","volume":"100","author":"Sadiq","year":"2011","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2017.04.032_bib14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1248\/bpb.b13-00773","article-title":"Proton-coupled organic cation antiporter-mediated uptake of apomorphine enantiomers in human brain capillary endothelial cell line hCMEC\/D3","volume":"37","author":"Okura","year":"2014","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.xphs.2017.04.032_bib15","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1002\/jps.24129","article-title":"Transport characteristics of tramadol in the blood\u2013brain barrier","volume":"103","author":"Kitamura","year":"2014","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2017.04.032_bib16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.dmpk.2014.12.006","article-title":"Memantine transport by a proton-coupled organic cation antiporter in hCMEC\/D3 cells, an in\u00a0vitro human blood-brain barrier model","volume":"30","author":"Higuchi","year":"2015","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.xphs.2017.04.032_bib17","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/jcbfm.2009.54","article-title":"Clonidine transport at the mouse blood-brain barrier by a new H+ antiporter that interacts with addictive drugs","volume":"29","author":"Andr\u00e9","year":"2009","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.xphs.2017.04.032_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1124\/dmd.105.006767","article-title":"Metabolism and disposition of varenicline, a selective \u03b14\u03b22 acetylcholine receptor partial agonist, in\u00a0vivo and in\u00a0vitro","volume":"34","author":"Obach","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.xphs.2017.04.032_bib19","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.clpt.6100405","article-title":"Effect of human renal cationic transporter inhibition on the pharmacokinetics of varenicline, a new therapy for smoking cessation: an in\u00a0vitro\u2013in\u00a0vivo study","volume":"83","author":"Feng","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.xphs.2017.04.032_bib20","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2133\/dmpk.DMPK-11-RG-156","article-title":"Renal tubular secretion of varenicline by multidrug and toxin extrusion (MATE) transporters","volume":"27","author":"Kajiwara","year":"2012","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.xphs.2017.04.032_bib21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neuint.2012.11.014","article-title":"Blood-to-brain influx transport of nicotine at the rat blood\u2013brain barrier: involvement of a pyrilamine-sensitive organic cation transport process","volume":"62","author":"Tega","year":"2013","journal-title":"Neurochem Int"},{"key":"10.1016\/j.xphs.2017.04.032_bib22","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1096\/fj.04-3458fje","article-title":"Blood-brain barrier-specific properties of a human adult brain endothelial cell line","volume":"19","author":"Weksler","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.xphs.2017.04.032_bib23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0378-5173(92)90006-N","article-title":"Determination of in\u00a0vivo steady-state unbound drug concentration in the brain interstitial fluid by microdialysis","volume":"81","author":"Terasaki","year":"1992","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2017.04.032_bib24","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1002\/jps.22594","article-title":"Functional characterization of rat plasma membrane monoamine transporter in the blood\u2013brain and blood\u2013cerebrospinal fluid barriers","volume":"100","author":"Okura","year":"2011","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2017.04.032_bib25","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/jps.24691","article-title":"Cocktail-dosing microdialysis study to simultaneously assess delivery to multiple organic-cationic drugs to the brain","volume":"105","author":"Kitamura","year":"2016","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2017.04.032_bib26","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0022-3565(25)13107-8","article-title":"Brain efflux index as a novel method of analyzing efflux transport at the blood-brain barrier","volume":"277","author":"Kakee","year":"1996","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.xphs.2017.04.032_bib27","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1124\/dmd.115.068932","article-title":"Development of a rat plasma and brain extracellular fluid pharmacokinetic model for bupropion and hydroxybupropion based on microdialysis sampling, and application to predict human brain concentrations","volume":"44","author":"Cremers","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.xphs.2017.04.032_bib28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.dmpk.2016.11.007","article-title":"Quantitative prediction of histamine H1 receptor occupancy by the sedative and non-sedative antagonists in the human central nervous system based on systemic exposure and preclinical data","volume":"32","author":"Kanamitsu","year":"2017","journal-title":"Drug Metab Pharmacokinet"},{"issue":"supplement 2","key":"10.1016\/j.xphs.2017.04.032_bib29","first-page":"1046","article-title":"Diphenhydramine as a selective probe to study H+-antiporter function at the blood-brain barrier: application to [11C]diphenhydramine positron emission tomography imaging","volume":"57","author":"Auvity","year":"2016","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.xphs.2017.04.032_bib30","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1111\/bph.13258","article-title":"Pharmacophore-based discovery of inhibitors of a novel drug\/proton antiporter in human brain endothelial hCMEC\/D3 cell line","volume":"172","author":"Chapy","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.xphs.2017.04.032_bib31","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.lfs.2007.01.035","article-title":"Blood-brain barrier transport of pramipexole, a dopamine D2 agonist","volume":"80","author":"Okura","year":"2007","journal-title":"Life Sci"},{"key":"10.1016\/j.xphs.2017.04.032_bib32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neuint.2015.12.011","article-title":"Functional expression of choline transporter like-protein 1 (CTL1) and CTL2 in human brain microvascular endothelial cells","volume":"93","author":"Iwao","year":"2016","journal-title":"Neurochem Int"},{"key":"10.1016\/j.xphs.2017.04.032_bib33","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/ntr\/ntv220","article-title":"Comparison of the\u00a0pharmacokinetics of nicotine following single and ad libitum use of a tobacco heating system or combustible cigarettes","volume":"18","author":"Picavet","year":"2016","journal-title":"Nicotine Tob Res"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354917302678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354917302678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:25:57Z","timestamp":1750206357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354917302678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0022354917302678"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2017.04.032","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of Proton-Coupled Organic Cation Antiporter in Varenicline Transport at Blood-Brain Barrier of Rats and in Human Brain Capillary Endothelial Cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2017.04.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}